Plaintiffs See Xarelto Lawsuit Numbers Grow To More Than 3,400 Cases Within 5 Years

March 21, 2016 – – BloodThinnerHelp.com reports on the number of Xarelto lawsuits filed over the last 5 years which have now surpassed 3,400 in number. In 2011, the new-generation anticoagulant gained approval from the U.S. Food and Drug Administration (FDA). When the drug initially went to market, it was tremendously popular and brought in lots of money for manufacturers Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson corporation). The drug was approved to treat patients recovering from hip and knee replacement surgeries, as well as those suffering from deep vein thrombosis, pulmonary embolism, or atrial fibrillation condition.

Today, the initial popularity of Xarelto has worn off some, and many consider the blood thinner to be incredibly dangerous. More than 3,400 lawsuits have been filed against Bayer and Janssen in reference to Xarelto and the dangers that plaintiffs allege it poses. These lawsuits have been filed by plaintiffs from all over the country, who share strikingly similar allegations that the blood thinner can cause increased risk of serious bleeding episodes in patients taking it, some of which plaintiffs claim have proven fatal for their loved ones.

These lawsuits, which continue to increase in number, were consolidated to form two major lawsuit groupings. In Eastern Louisiana, the U.S. Judicial Panel on Multidistrict Litigation (JPML) transferred all federally-filed Xarelto complaints to a single court. This consolidation formed Multidistrict Litigation No. 2592, which is being overseen by the Honorable Judge Eldon Fallon. The complaints involved in this MDL number over 2,800 at this time, and are joined by another group of more than 600 others which were consolidated in Philadelphia, Pennsylvania by the Court of Common Pleas, forming a mass tort program.

Xarelto has also been given two ‘black box’ warnings from the FDA. These warnings are the most strict warnings a product can receive before being pulled completely from the market. The drug and manufacturers have been in the spotlight again recently as new controversies have been exposed. European Regulators announced that they were starting an investigation regarding the clinical trials conducted on the drug, and on data (or a lack of data) which was provided to prestigious medical journals after clinical trials, which may have led to a premature FDA approval for Xarelto.

As the plaintiffs currently involved await additional answers from these pending investigations, Attorney Joseph Osborne is working to help ensure that everyone who has taken Xarelto and who has suffered from health complications that they attribute to their use of the drug will be given the important opportunity to explore their legal rights in full. These individuals may be entitled to legal action and substantial compensation. To better help patients looking to pursue justice, Attorney Osborne is currently offering free legal consultations for those affected.

To ask questions regarding Xarelto lawsuits, or to request additional information, please contact Attorney Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008797